How much is a share of DMT worth?
One share of DMT stock can currently be purchased for approximately C$0.23. How much money does Small Pharma make? Small Pharma has a market capitalization of C$71.51 million and generates C$-1.16 thousand in revenue each year.
Where can I buy shares of dmtk?
Shares of DMTK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Who bought dermtech (dmtk) stock?
DMTK stock was purchased by a variety of institutional investors in the last quarter, including Aegon Asset Management UK PLC, National Bank of Canada FI, and Epiq Partners LLC. Company insiders that have bought DermTech stock in the last two years include Enrico Picozza, Matthew L Posard, Mutual Insurance Co Donegal, and Rtw Investments, Lp.
What are analysts'price targets for dermtech's stock?
7 equities research analysts have issued 12-month price targets for DermTech's stock. Their forecasts range from $20.00 to $79.00. On average, they anticipate DermTech's stock price to reach $56.00 in the next twelve months. This suggests a possible upside of 26.1% from the stock's current price.
Is DMT stock a buy right now?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Small Pharma in the last twelve months. There are currently 2 buy ratings...
Will Small Pharma's stock price go up in 2022?
2 Wall Street analysts have issued 1-year target prices for Small Pharma's shares. Their forecasts range from C$1.00 to C$1.00. On average, they an...
How has Small Pharma's stock price performed in 2022?
Small Pharma's stock was trading at C$0.32 at the beginning of 2022. Since then, DMT stock has decreased by 56.3% and is now trading at C$0.14. Vi...
When is Small Pharma's next earnings date?
Small Pharma is scheduled to release its next quarterly earnings announcement on Friday, July 29th 2022. View our earnings forecast for Small Phar...
Who are Small Pharma's key executives?
Small Pharma's management team includes the following people: Mr. Peter David Rands , CEO & Founder Mr. David Steel , Chief Financial Officer Ms...
Who are some of Small Pharma's key competitors?
Some companies that are related to Small Pharma include BriaCell Therapeutics (BCT) , Redx Pharma (REDX) , ImmunoPrecise Antibodies (IPA) , Amp...
What is Small Pharma's stock symbol?
Small Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "DMT."
How do I buy shares of Small Pharma?
Shares of DMT and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian...
What is Small Pharma's stock price today?
One share of DMT stock can currently be purchased for approximately C$0.14.
Small Pharma Reports Fiscal Third Quarter 2021 Highlights
Small Pharma to Attend Upcoming Healthcare Conferences in January 2022
Significant progress made across the clinical portfolio with lead candidate advancing through trialsLONDON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc.
Small Pharma to Participate in the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6, 2021
LONDON, United Kingdom, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce its attendance at the 11th Annual LifeSci Partners Annual Corporate Access Event, and the H.C.